Intellia, ReCode partner on genetic medicines for cystic fibrosis
Bio Pharma Dive
FEBRUARY 15, 2024
The partnership will use Intellia's "DNA writing” technology, and initially focus on people with the lung disease who have limited or no available treatment options.
Let's personalize your content